Abstract: Disclosed area coating-free metallic thermoplastic resin composition having improved metallic texture and gloss and a molded product having extrusion-molded the same. For example, the molded produce may be manufactured by feeding a master batch containing a styrene-acrylonitrile (SAN) resin and a metal in a weather resistant thermoplastic resin containing an acrylonitrile styrene acrylate (ASA) resin in a side feeding method. The coating-free metallic thermoplastic resin composition may be optimized in types and contents of the master batch and dispersant contained therein. The molded product may be manufactured by feeding the master batch in the side feeding method to improve various physical properties, increase the dispensability and compatibility between compositions, and improve black streaks and flow marks, thereby improving metallic texture and gloss as well as suppressing the occurrence of the appearance defects.

Abstract: Provided is a substrate treatment apparatus including a treatment container equipped with a conductive member. The conductive member is made of a material having a lower resistivity than that of the treatment container. The conductive member prevents a rise of an electric potential of the treatment container, which is caused by charging during treatment of a substrate, thereby preventing the substrate from being contaminated and damaged by particles and electrostatic arcing.

Abstract: The present invention provides a programmable long-range wireless signal remote control device that receives a wireless signal through a processor, performs a verification procedure on the wireless signal by using a signal packet data protocol entity, and then utilizes a control transmission interface to transmit the control signal in the wireless signal to a processing component. A sequence data control interface transmits a data signal in the wireless signal externally, and a programmable entity controls a number of sequences and the time of transmitting the wireless signal or a control signal externally, thereby achieving the effect of information preservation and data identification, the reception and transmission of stable signals, transmission of the control signal in a one-to-many time-series interval manner, and the provision of the control signal and the data signal to a controlled device.

Abstract: A signal transmission method for lightweight remote control communication protocol is provided. According to the method, a signal-controlled-end transceiver executes a communication transmission process according to a communication protocol to receive a communication signal. The communication transmission process includes determining whether the payload column of the communication signal is encrypted and determining whether the communication signal is a single-direction or a dual-direction communication signal. Besides, the communication signal further includes a control data and an information data. In this way, when a controlled device receives the communication signal, the control element of the controlled device controls the controlled device according to the control data and the information data.

Abstract: The present invention relates to a liposomal lupeol acetate (Lipo-LA) and its use in the treatment or prevention of rheumatoid arthritis (RA). The liposomal lupeol acetate of the present invention especially inhibits inflammatory responses and osteoclast generation (osteoclastogenesis) in the progression of rheumatoid arthritis (RA) at a half dose of the un-capsulated lupeol acetate, which may significantly reduce the incidence of RA and improve the therapeutic efficacy of lupeol acetate.

Abstract: A method of producing a layer structure includes forming a first organic layer by applying a first composition including an organic compound on a substrate having a plurality of patterns, applying a solvent on the first organic layer to remove a part of the first organic layer, and applying a second composition including an organic compound on a remaining part of the first organic layer and forming a second organic layer through a curing process.

Abstract: The present invention relates to synergistic combinations of lupeol acetate and curcumin at low dosage, and their use for the treatment or prevention of osteoporosis.

Abstract: Provided is a substrate treating apparatus. The substrate treating apparatus includes a treating container having an opened upper portion, a substrate heating unit heating a substrate disposed in the treating container while supporting the substrate, and a treating solution supply unit supplying a treating solution onto the substrate disposed on the substrate heating unit. The substrate heating unit includes a rotatable chuck stage on which the substrate is placed, a rotation part having a hollow shape, the rotation part being coupled to the chuck stage to rotate the chuck stage, and a heat generation part disposed in the chuck stage.

Abstract: Provided is a thin film battery module. The thin film battery module comprises: a battery module which is configured of unit cells stacked against each other; and a shock absorbing portion which surrounds the space between the unit cells and the battery module. Also provided are a thin film battery package, a thin film battery package manufacturing device, and a thin film battery package manufacturing method.

Abstract: A poorly soluble drug containing microsphere with improved bioavailability, an oral formulation comprising the same, and a method of preparing the same are provided, wherein the poorly soluble drug containing microsphere is a solid dispersion wherein the poorly soluble drug is dispersed in the water-soluble polymer carrier in a noncrystalline form by spray drying, thus increasing bioavailability of the poorly soluble drug.

Abstract: The present invention relates to synergistic combinations of lupeol acetate and curcumin at low dosage, and their use for the treatment or prevention of activated osteoclast precursor related diseases, including rheumatoid arthritis and osteoporosis.

Abstract: A method of producing a layer structure includes forming a first organic layer by applying a first composition including an organic compound on a substrate having a plurality of patterns, applying a solvent on the first organic layer to remove a part of the first organic layer, and applying a second composition including an organic compound on a remaining part of the first organic layer and forming a second organic layer through a curing process.

Abstract: The present invention relates to a liposomal lupeol acetate (Lipo-LA) and its use in the treatment or prevention of rheumatoid arthritis (RA). The liposomal lupeol acetate of the present invention especially inhibits inflammatory responses and osteoclast generation (osteoclastogenesis) in the progression of rheumatoid arthritis (RA) at a half dose of the un-capsulated lupeol acetate, which may significantly reduce the incidence of RA and improve the therapeutic efficacy of lupeol acetate.

Abstract: Provided is a substrate treating apparatus. The substrate treating apparatus includes a treating container having an opened upper portion, a substrate heating unit heating a substrate disposed in the treating container while supporting the substrate, and a treating solution supply unit supplying a treating solution onto the substrate disposed on the substrate heating unit. The substrate heating unit includes a rotatable chuck stage on which the substrate is placed, a rotation part having a hollow shape, the rotation part being coupled to the chuck stage to rotate the chuck stage, and a heat generation part disposed in the chuck stage.

Abstract: Provided is a thin film battery module. The thin film battery module comprises: a battery module which is configured of unit cells stacked against each other; and a shock absorbing portion which surrounds the space between the unit cells and the battery module. Also provided are a thin film battery package, a thin film battery package manufacturing device, and a thin film battery package manufacturing method.

Abstract: A method of increasing immunity of a subject by administering an antidepressant to the subject is disclosed in the present invention. Preferably, the antidepressant is mirtazapine. And further, another object of the present invention is related to a method of administering the abovementioned antidepressant to the subject for treating cancer. The present invention tries to find the mechanism of the tumor growth inhibition by mirtazapine, and it may be due to the alteration of the tumor microenvironment, which involves the activation of the immune response and the recovery of serotonin level.

Abstract: A poorly soluble drug containing microsphere with improved bioavailability, an oral formulation comprising the same, and a method of preparing the same are provided, wherein the poorly soluble drug containing microsphere is a solid dispersion wherein the poorly soluble drug is dispersed in the water-soluble polymer carrier in a noncrystalline form by spray drying, thus increasing bioavailability of the poorly soluble drug.

Abstract: A computer system includes a system part, a connector to which an external device is connected, a communication unit which performs communication with the external device, and a control unit which is connected between the connector and the communication unit to monitor a state of a predetermined recognition signal applied from the external device when the system part is in a standby mode. The control unit performs a predetermined function corresponding to the monitored state of the recognition signal. When the system part is in the standby mode, the system part may be switched to an operation mode based on the recognition signal from the external device. Additionally, a predetermined charging power is output to an external device in response to the predetermined recognition signal applied from the external device connected to the connector while the system part exists in the standby mode.